Clinical Trial

Berlin-Brandenburg Pregnancy Cohort

Study acronym: BBPC
Recruiting
View on ClinicalTrials.gov →
Summary
This study will investigate the interplay of different immune cells and placental cells as well as their potential for the development of pregnancy complications. In particular, the translation of the uteroplacental syndrome into a maternal syndrome, considered in the multifactorial pregnancy disorder preeclampsia, will be investigated. Immune cell subtypes are causally involved in the formation and translation of preeclampsia by inducing an endothelial dysfunction which leads to cardiovascular damage.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2017-10-13.
Trial Details
NCT Number NCT03313024
Lead Sponsor Charite University, Berlin, Germany
Conditions Preeclampsia, Pregnancy Complications, Diabetes Mellitus in Pregnancy
Enrollment 1,580 participants
Start Date 2017-09-26
Primary Completion 2027-10 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2018-08-14